Ceftriaxone Kalceks

Ceftriaxone Kalceks is indicated for the treatment of the following infections in adults and children including term neonates (from birth):

• bacterial meningitis;
• community acquired pneumonia;
• hospital acquired pneumonia;
• acute otitis media;
• intra-abdominal infections;
• complicated urinary tract infections (including pyelonephritis);
• infections of bones and joints;
• complicated skin and soft tissue infections;
• gonorrhoea;
• syphilis;
• bacterial endocarditis.

Ceftriaxone Kalceks may be used:

• for treatment of acute exacerbations of chronic obstructive pulmonary disease in adults;
• for treatment of disseminated Lyme borreliosis (early [stage II] and late [stage III]) in adults and children including neonates from 15 days of age;
• for pre-operative prophylaxis of surgical site infections;
• in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection;
• in the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.

Prescription-only medicine. Information for healthcare professionals only.
For full information about this medicine, refer to the Summary of Product Characteristics.
Advertisement developed or revised 05/2026. Advertiser: AS Kalceks.